- Nachrichtendetail
-
05.03.2024 15:02:08 - dpa-AFX: *NEKTAR INITIATES PHASE 2B STUDY OF REZPEGALDESLEUKIN IN SEVERE ALOPECIA AREATA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
NEKTAR THERAPEUTICS | 165417 | Frankfurt | 1,053 | 24.06.24 08:05:48 | +0,041 | +4,05% | 1,051 | 1,073 | 1,053 | 1,012 |
